{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"136","value":"5280"},{"groupId":"OG001","spread":"136","value":"5280"},{"groupId":"OG002","spread":"198","value":"2753"},{"groupId":"OG003","spread":"69","value":"1891"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"5"}],"units":"Participants"}],"description":"Area under plasma Concentration (AUC) 0 to t","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Defactinib 400 mg BID for 12 days","id":"OG000","title":"Cohort 1"},{"description":"Defactinib 400 mg BID for 35 days","id":"OG001","title":"Cohort 2 (Fasted)"},{"description":"Defactinib 400 mg for 21 days","id":"OG002","title":"Cohort 3 (Fed)"},{"description":"Defactinib 100 mg BID for 21 days","id":"OG003","title":"Cohort 4 (Fasted)"}],"paramType":"GEOMETRIC_MEAN","reportingStatus":"POSTED","timeFrame":"0-8 hours","title":"Evaluate the Pharmacokinetics of VS-6063 (Defactinib), AUC (Area Under the Curve)","type":"PRIMARY","unitOfMeasure":"ng*h/mL"}